Catalyst Wire Dossier Catalyst Wire Dossier

GSK2647544

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK2647544, covering 2017-10-18 to 2017-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers [Phase 1]

See pricing